Insider · CIK 0001366074
Mark Lappe
Files at INBX (Inhibrx Biosciences, Inc.). First filing Sep 8, 2026, latest Sep 28, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
INBX: Inhibrx Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | Inhibrx Biosciences, Inc. | $999k 10,000 shares | +1% | - | |
| 65Notable | Inhibrx Biosciences, Inc. | $2.6M 25,000 shares | +4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | INBX Inhibrx Biosciences, Inc. | POpen-market purchase Common Stockindirect: By the Lappe Family Trust | +3,324 | $98.87 | $329k | 733,872 | 14 d ago |
| Sep 25, 2026 | INBX Inhibrx Biosciences, Inc. | POpen-market purchase Common Stockindirect: By the Lappe Family Trust | +2,176 | $99.60 | $217k | 736,048 | 14 d ago |
| Sep 28, 2026 | INBX Inhibrx Biosciences, Inc. | POpen-market purchase Common Stockindirect: By the Lappe Family Trust | +1,500 | $98.88 | $148k | 737,548 | 14 d ago |
| Sep 28, 2026 | INBX Inhibrx Biosciences, Inc. | POpen-market purchase Common Stockindirect: By the Lappe Family Trust | +3,000 | $101.70 | $305k | 740,548 | 14 d ago |
| Sep 8, 2026 | INBX Inhibrx Biosciences, Inc. | POpen-market purchase Common Stockindirect: By the Lappe Family Trust | +5,895 | $99.29 | $585k | 711,443 | 34 d ago |
| Sep 8, 2026 | INBX Inhibrx Biosciences, Inc. | POpen-market purchase Common Stockindirect: By the Lappe Family Trust | +6,605 | $100.64 | $665k | 718,048 | 34 d ago |
| Sep 8, 2026 | INBX Inhibrx Biosciences, Inc. | POpen-market purchase Common Stockindirect: By the Lappe Family Trust | +1,100 | $107.12 | $118k | 719,148 | 34 d ago |
| Sep 8, 2026 | INBX Inhibrx Biosciences, Inc. | POpen-market purchase Common Stockindirect: By the Lappe Family Trust | +500 | $108.24 | $54k | 719,648 | 34 d ago |
| Sep 8, 2026 | INBX Inhibrx Biosciences, Inc. | POpen-market purchase Common Stockindirect: By the Lappe Family Trust | +1,219 | $111.88 | $136k | 720,867 | 34 d ago |
| Sep 8, 2026 | INBX Inhibrx Biosciences, Inc. | POpen-market purchase Common Stockindirect: By the Lappe Family Trust | +9,681 | $112.28 | $1.1M | 730,548 | 34 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.